Catalytic subunit of human telomerase reverse transcriptase is an independent predictor of survival in patients undergoing curative resection of hepatic colorectal metastases: A multicenter analysis

Journal of Clinical Oncology

Volumn 23, Issue 13, 2005, Pages 3086-3093

  Dômont, Julien ^a   Pawlik, Timothy M ^a   Boige, Valérie ^a   Rose, Mathieu ^a   Weber, Jean Christophe ^a   Hoff, Paulo M ^a   Brown, Thomas D ^a   Zorzi, Daria ^a   Morat, Luc ^a   Pignon, Jean Pierre ^a   Rashid, Asif ^a   Jaeck, Daniel ^a   Sabatier, Laure ^a   Elias, Dominique ^a   Tursz, Thomas ^a   Soria, Jean Charles ^a   Vauthey, Jean Nicolas ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; KI 67 ANTIGEN; TELOMERASE REVERSE TRANSCRIPTASE; DNA BINDING PROTEIN; TELOMERASE;

ADULT; AGED; ARTICLE; CANCER SURGERY; CATALYSIS; COLORECTAL CANCER; DATA ANALYSIS; DISEASE FREE SURVIVAL; DISEASE MARKER; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCORING SYSTEM; SURVIVAL; UNIVARIATE ANALYSIS; COLORECTAL TUMOR; ENZYME ACTIVE SITE; GENE EXPRESSION PROFILING; GENETICS; LIVER TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING;

ADULT; AGED; AGED, 80 AND OVER; CATALYTIC DOMAIN; COLORECTAL NEOPLASMS; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS; TELOMERASE;

EID: 21144437706     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.06.944     Document Type: Article

References (50)

1. Jemal A, Murray T, Samuels A, et al: Cancer statistics, 2003. CA Cancer J Clin 53:5-26, 2003
2. Lise M, Bacchetti S, Da Pian P, et al: Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: Results in a series of 100 Italian patients. Cancer 82:1028-1036, 1998
3. Nordlinger B, Guiguet M, Vaillant JC, et al: Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patients-Association Francaise de Chirurgie. Cancer 77:1254-1262, 1996
4. A. Choti MA, Sitzmann JV, Tiburi MF, et al: Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759-766, 2002
5. Abdalla EK, Vauthey JN, Ellis LM, et al: Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239:818-825, 2004
6. Fong Y, Fortner J, Sun RL, et al: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 230:309-318, 1999
7. Weber JC, Nakano H, Bachellier P, et al: Is a proliferation index of cancer cells a reliable prognostic factor after hepatectomy in patients with colorectal liver metastases? Am J Surg 182:81-88, 2001
8. Nitti D, Belluco C, Montesco MC, et al: Nuclear p53 protein expression in resected hepatic metastases from colorectal cancer: An independent prognostic factor of survival. Eur J Cancer 34:851-855, 1998
9. Gonen M, Hummer A, Zervoudakis A, et al: Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer. J Clin Oncol 21:406-112, 2003
10. De Jong KP, Lont HE, Bijma AM, et al: The effect of partial hepatectomy on tumor growth in rats: In vivo and in vitro studies. Hepatology 22:1263-1272, 1995
11. Smith DL, Soria JC, Morat L, et al: Human telomerase reverse transcriptase (hTERT) and Ki-67 are better predictors of survival than established clinical indicators in patients undergoing curative hepatic resection for colorectal metastases. Ann Surg Oncol 11:45-51, 2004
12. Petrowsky H, Sturm I, Graubitz O, et al: Relevance of Ki-67 antigen expression and K-ras mutation in colorectal liver metastases. Eur J Surg Oncol 27:80-87, 2001
13. De Jong KP, Stellema R, Karrenbeld A, et al: Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors. Hepatology 28:971-979, 1998
14. Costa A, Doci R, Mochen C, et al: Cell proliferation-related markers in colorectal liver metastases: Correlation with patient prognosis. J Clin Oncol 15:2008-2014, 1997
15. Moyzis RK, Buckingham JM, Cram LS, et al: A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci U S A 85: 6622-6626, 1988
16. Blackburn EH: Structure and function of telomeres. Nature 350:569-573, 1991
17. Greider CW: Telomeres. Curr Opin Cell Biol 3:444-451, 1991
18. Shore D: Telomerase and telomere-binding proteins: Controlling the endgame. Trends Biochem Sci 22:233-235, 1997
19. Harvey JH, Smith FP, Schein PS: 5-Flourouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract. J Clin Oncol 2:1245-1248, 1984
20. Lindsey J, McGill NI, Lindsey LA, et al: In vivo loss of telomeric repeats with age in humans. Mutat Res 256:45-48, 1991
21. Vaziri H, Dragowska W, Allsopp RC, et al: Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age. Proc Natl Acad Sci U S A 91:9857-9860, 1994
22. Shay JW, Werbin H, Wright WE: Telomeres and telomerase in human leukemias. Leukemia 10:1255-1261, 1996
23. Shay JW, Wright WE: The reactivation of telomerase activity in cancer progression. Trends Genet 12:129-131, 1996
24. Shay JW, Wright WE: Telomerase activity in human cancer. Curr Opin Oncol 8:66-71, 1996
25. Kim NW, Piatyszek MA, Prowse KR, et al: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994
26. Yoo J, Park SY, Kang SJ, et al: Expression of telomerase activity, human telomerase RNA, and telomerase reverse transcriptase in gastric adenocarcinomas. Mod Pathol 16:700-707, 2003
27. Lantuejoul S, Soria JC, Moro-Sibilot D, et al: Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours. Br J Cancer 90:1222-1229, 2004
28. Kanaya T, Kyo S, Takakura M, et al: HTERT is a critical determinant of telomerase activity in renal-cell carcinoma. Int J Cancer 78:539-543, 1998
29. Liu YC, Chen CJ, Wu HS, et al: Telomerase and c-myc expression in hepatocellular carcinomas. Eur J Surg Oncol 30:384-390, 2004
30. Niiyama H, Mizumoto K, Sato N, et al: Quantitative analysis of hTERT mRNA expression in colorectal cancer. Am J Gastroenterol 96:1895-1900, 2001
31. Chadeneau C, Hay K, Hirte HW, et al: Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 55:2533-2536, 1995
32. Yang Y, Chen Y, Zhang C, et al: Nucleolar localization of hTERT protein is associated with telomerase function. Exp Cell Res 277:201-209, 2002
33. Etheridge KT, Banik SS, Armbruster BN, et al: The nucleolar localization domain of the catalytic subunit of human telomerase. J Biol Chem 277:24764-24770, 2002
34. Vauthey JN, Pawlik TM, Abdalla EK, et al: Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg 239:722-732, 2004
35. Rosen CB, Nagorney DM, Taswell HF, et al: Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 216:493-505, 1992
36. Hughes KS, Simon R, Songhorabodi S, et al: Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of patterns of recurrence. Surgery 100:278-284, 1986
37. Scheele J, Stang R, Altendorf-Hofmann A, et al: Resection of colorectal liver metastases. World J Surg 19:59-71, 1995
38. Fong Y, Cohen AM, Fortner JG, et al: Liver resection for colorectal metastases. J Clin Oncol 15:938-946, 1997
39. Gayowski TJ, Iwatsuki S, Madariaga JR, et al: Experience in hepatic resection for metastatic colorectal cancer: Analysis of clinical and pathologic risk factors. Surgery 116:703-710, 1994
40. Resection of the liver for colorectal carcinoma metastases: A multi- institutional study of indications for resection-Registry of Hepatic Metastases. Surgery 103:278-288, 1988
41. Fortner JG, Silva JS, Cox EB, et al: Multivariate analysis of a personal series of 247 patients with liver metastases from colorectal cancer, II: Treatment by intrahepatic chemotherapy. Ann Surg 199:317-324, 1984
42. August DA, Sugarbaker PH, Ottow RT, et al: Hepatic resection of colorectal metastases: Influence of clinical factors and adjuvant intraperitoneal 5-fluorouracil via Tenckhoff catheter on survival. Ann Surg 201:210-218, 1985
43. Bengmark S, Hafstrom L, Jeppsson B, et al: Metastatic disease in the liver from colorectal cancer: An appraisal of liver surgery. World J Surg 6:61-65, 1982
44. Belluco C, Guillem JG, Kemeny N, et al: p53 nuclear protein overexpression in colorectal cancer: A dominant predictor of survival in patients with advanced hepatic metastases. J Clin Oncol 14:2696-2701, 1996
45. Crowe PJ, Yang JL, Berney CR, et al: Genetic markers of survival and liver recurrence after resection of liver metastases from colorectal cancer. World J Surg 25:996-1001, 2001
46. Lind DS, Parker GA, Horsley JS 3rd, et al: Formal hepatic resection of colorectal liver metastases: Ploidy and prognosis. Ann Surg 215: 677-684, 1992
47. Saw RP, Koorey D, Painter D, et al: p53, DCC and thymidylate synthase as predictors of survival after resection of hepatic metastases from colorectal cancer. Br J Surg 89:1409-1415, 2002
48. Van P, Benhattar J, Seelentag W, et al: Immunohistochemical localization of hTERT protein in human tissues. Histochem Cell Biol 121: 391-397, 2004
49. Shoji Y, Yoshinaga K, Inoue A, et al: Quantification of telomerase activity in sporadic colorectal carcinoma: Association with tumor growth and venous invasion. Cancer 88:1304-1309, 2000
50. Wei R, Younes M: Immunohistochemical detection of telomerase reverse transcriptase in colorectal adenocarcinoma and benign colonic mucosa. Hum Pathol 33:693-696, 2002